IL6 and inflammatory breast carcinoma: In inflammatory breast cancer, XIAP overexpression compared to non-inflammatory breast cancer is associated with elevated TNF-α/IL-6 levels and poorer survival, linking apoptosis resistance to an aggressive phenotype (Van Berckelaer et al., 2024[62]).